SSA
AEMD icon

Schonfeld Strategic Advisors’s Aethlon Medical AEMD Stock Holding History

Schonfeld Strategic Advisors’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-21
Closed -$41K – 1754
2020
Q4 		$41K Buy
+21
New +$28.1K ﹤0.01% 1504

Other funds holding AEMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
CCP
Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CFN
Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return

Schonfeld Strategic Advisors's AEMD Position: Q1 2021 in Review

Schonfeld Strategic Advisors sold out of Aethlon Medical (AEMD) in Q1 2021, closing a stake of 21 shares — an estimated $41K sold.

Schonfeld Strategic Advisors first reported a position in AEMD in Q4 2020 and held it in 1 quarter. The position peaked at $41K in Q4 2020. 18 funds tracked by Wall St. Rank hold AEMD as of Q1 2021.

  • Schonfeld Strategic Advisors reported no remaining Aethlon Medical position as of Q1 2021 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 21 Aethlon Medical shares in Q1 2021, an estimated $41K.
  • Schonfeld Strategic Advisors first reported a position in Aethlon Medical in Q4 2020 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Aethlon Medical position peaked at $41K in Q4 2020.
  • 18 funds tracked by Wall St. Rank held Aethlon Medical as of Q1 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2021, filed 17 May 2021.